SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001741830-21-000041
Filing Date
2021-08-12
Accepted
2021-08-12 16:31:54
Documents
69
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q kron-20210630.htm   iXBRL 10-Q 1637564
2 EX-31.1 kronq2fy2021ex311.htm EX-31.1 18561
3 EX-31.2 kronq2fy2021ex312.htm EX-31.2 18515
4 EX-32.1 kronq2fy2021ex321.htm EX-32.1 11469
10 kron-20210630_g1.jpg GRAPHIC 185315
  Complete submission text file 0001741830-21-000041.txt   7151686

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kron-20210630.xsd EX-101.SCH 41974
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kron-20210630_cal.xml EX-101.CAL 70823
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kron-20210630_def.xml EX-101.DEF 200476
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kron-20210630_lab.xml EX-101.LAB 531808
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kron-20210630_pre.xml EX-101.PRE 347934
11 EXTRACTED XBRL INSTANCE DOCUMENT kron-20210630_htm.xml XML 1118810
Mailing Address 1300 S. EL CAMINO REAL SUITE 300 SAN MATEO CA 94402
Business Address 1300 S. EL CAMINO REAL SUITE 300 SAN MATEO CA 94402 212-871-7920
Kronos Bio, Inc. (Filer) CIK: 0001741830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39592 | Film No.: 211168101
SIC: 2834 Pharmaceutical Preparations